Paper38859778
Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer Agents.
Martino E and 6 others. Mini Rev Med Chem, 2024. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer Agents. Papers, record 38859778. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38859778
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histone Deacetylase Inhibitors | Major topic |
| Quinazolines | Major topic |
| Antineoplastic Agents | Major topic |
| Histone Deacetylases | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Structure-Activity Relationship | |
| Animals | |
| Molecular Structure |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17320507 | Chromatin modifications and their function. | Cell | 2007 | https://conductscience.org/library/papers/17320507 | PubMed |
| 2 | 32987782 | Bifunctional HDAC Therapeutics: One Drug to Rule Them All? | Molecules | 2020 | https://conductscience.org/library/papers/32987782 | PubMed |
| 3 | 26759180 | A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells. | Mol Biosyst | 2016 | https://conductscience.org/library/papers/26759180 | PubMed |
| 4 | 15050820 | Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. | J Mol Biol | 2004 | https://conductscience.org/library/papers/15050820 | PubMed |
| 5 | 21076528 | The role of HDAC6 in cancer. | J Biomed Biotechnol | 2011 | https://conductscience.org/library/papers/21076528 | PubMed |
| 6 | 17694083 | Histone deacetylases and cancer. | Oncogene | 2007 | https://conductscience.org/library/papers/17694083 | PubMed |
| 7 | 18568166 | Isoform-selective histone deacetylase inhibitors. | Chem Soc Rev | 2008 | https://conductscience.org/library/papers/18568166 | PubMed |
| 8 | 29733427 | Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer. | Med Res Rev | 2018 | https://conductscience.org/library/papers/29733427 | PubMed |
| 9 | 16955068 | Anticancer activities of histone deacetylase inhibitors. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/16955068 | PubMed |
| 10 | 33117804 | The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33117804 | PubMed |
| 11 | 28947154 | Design, synthesis and biological evaluation of novel histone deacetylase inhibitors incorporating 4-aminoquinazolinyl systems as capping groups. | Bioorg Med Chem Lett | 2017 | https://conductscience.org/library/papers/28947154 | PubMed |
| 12 | 26443078 | Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer. | J Med Chem | 2016 | https://conductscience.org/library/papers/26443078 | PubMed |
| 13 | 35408693 | Quinazoline Based HDAC Dual Inhibitors as Potential Anti-Cancer Agents. | Molecules | 2022 | https://conductscience.org/library/papers/35408693 | PubMed |
| 14 | 37098307 | Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/37098307 | PubMed |
| 15 | 37079967 | Design, synthesis and bioactivity evaluations of 8-substituted-quinoline-2-carboxamide derivatives as novel histone deacetylase (HDAC) inhibitors. | Bioorg Med Chem | 2023 | https://conductscience.org/library/papers/37079967 | PubMed |
| 16 | 36924653 | Structural optimization of tetrahydroisoquinoline-hydroxamate hybrids as potent dual ERα degraders and HDAC inhibitors. | Bioorg Chem | 2023 | https://conductscience.org/library/papers/36924653 | PubMed |
| 17 | 36996717 | Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/36996717 | PubMed |
| 18 | 36645952 | Synthesis and biological evaluation of novel N-benzyltriazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors. | Bioorg Med Chem | 2023 | https://conductscience.org/library/papers/36645952 | PubMed |
| 19 | 35425078 | Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring. | RSC Adv | 2022 | https://conductscience.org/library/papers/35425078 | PubMed |
| 20 | 33077264 | Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33077264 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41920754 | Medicinal Chemistry of Fourth-generation Tyrosine Kinase Inhibitors. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41920754 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HDAC9 | 9734 | PubTator's text mining | https://conductscience.org/library/genes/9734 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38859778
GET https://conductscience.org/api/papers/v1/38859778/references?page=2